Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alp Tuna Beksac

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Journal of Robotic Surgery|September 28, 2019
A multi-institutional analysis of 263 hilar tumors during robot-assisted partial nephrectomyPeter L Sunaryo, David J Paulucci, Kennedy Okhawere, et al.
Urologic Oncology|April 8, 2018
Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative diseaseKetan K Badani, Balaji N Reddy, Eric J Moskowitz, et al.
Urology|February 14, 2019
Downgrading of Grade Group After Radical Prostatectomy: Comparison of Multiparametric Magnetic Resonance Imaging Guided Fusion Biopsy and Standard 12-Core BiopsyAlp Tuna Beksac, Stanislaw Sobotka, Paige Xu, et al.
BJU International|December 10, 2024
Novel bioabsorbable, low-dose rate brachytherapy device (CivaSheet<sup>®</sup>) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancerKennedy E Okhawere, Shirin Razdan, Alp Tuna Beksac, et al.
Journal of Endourology|June 30, 2020
Should a Drain Be Routinely Required After Transperitoneal Robotic Partial Nephrectomy?Alp Tuna Beksac, Kennedy E Okhawere, Kirolos Meilika, et al.
Cancer Reports (Hoboken, N.J.)|December 21, 2021
Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancerAlp Tuna Beksac, Parita Ratnani, Zachary Dovey, et al.
World Journal of Urology|August 4, 2016
Impact of tumor histology and grade on treatment success of percutaneous renal cryoablationAlp Tuna Beksac, Gerant Rivera-Sanfeliz, Catherine A Dufour, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 1, 2019
Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic scoreIvan Jambor, Ugo Falagario, Parita Ratnani, et al.
Urologic Oncology|June 9, 2019
Trends and outcomes in contemporary management renal cell carcinoma and vena cava thrombusAlp Tuna Beksac, Qainat N Shah, David J Paulucci, et al.
The Journal of Urology|February 8, 2019
Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Imaging and Genomic TestsUgo G Falagario, Alp Tuna Beksac, Alberto Martini, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Journal of Robotic Surgery|September 28, 2019
A multi-institutional analysis of 263 hilar tumors during robot-assisted partial nephrectomyPeter L Sunaryo, David J Paulucci, Kennedy Okhawere, et al.
Urologic Oncology|April 8, 2018
Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative diseaseKetan K Badani, Balaji N Reddy, Eric J Moskowitz, et al.
Urology|February 14, 2019
Downgrading of Grade Group After Radical Prostatectomy: Comparison of Multiparametric Magnetic Resonance Imaging Guided Fusion Biopsy and Standard 12-Core BiopsyAlp Tuna Beksac, Stanislaw Sobotka, Paige Xu, et al.
BJU International|December 10, 2024
Novel bioabsorbable, low-dose rate brachytherapy device (CivaSheet<sup>®</sup>) with radical prostatectomy and adjuvant external beam radiation for the management of prostate cancerKennedy E Okhawere, Shirin Razdan, Alp Tuna Beksac, et al.
Journal of Endourology|June 30, 2020
Should a Drain Be Routinely Required After Transperitoneal Robotic Partial Nephrectomy?Alp Tuna Beksac, Kennedy E Okhawere, Kirolos Meilika, et al.
Cancer Reports (Hoboken, N.J.)|December 21, 2021
Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancerAlp Tuna Beksac, Parita Ratnani, Zachary Dovey, et al.
World Journal of Urology|August 4, 2016
Impact of tumor histology and grade on treatment success of percutaneous renal cryoablationAlp Tuna Beksac, Gerant Rivera-Sanfeliz, Catherine A Dufour, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 1, 2019
Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic scoreIvan Jambor, Ugo Falagario, Parita Ratnani, et al.
Urologic Oncology|June 9, 2019
Trends and outcomes in contemporary management renal cell carcinoma and vena cava thrombusAlp Tuna Beksac, Qainat N Shah, David J Paulucci, et al.
The Journal of Urology|February 8, 2019
Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Imaging and Genomic TestsUgo G Falagario, Alp Tuna Beksac, Alberto Martini, et al.
Pageof 7